| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1259319C Dimer cyanine dye in use for DVD-R at high speed, and synthesis method |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060822 2-pyrazolin-5-ones |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060703 Indolinone derivatives |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060110 Chromatic direct dyes |
| 06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/08/2006 | WO2006060678A2 Novel processes for the preparation of cgrp-receptor antagonists and intermediates thereof |
| 06/08/2006 | WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | WO2006060198A1 Translation lookaside buffer (tlb) access supression for intra-page program counter relative or absolute address branch instructions |
| 06/08/2006 | WO2006060127A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/08/2006 | WO2006060122A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059234A2 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | WO2006058753A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 06/08/2006 | WO2006058720A2 Novel compounds for the treatment of neurological disorders |
| 06/08/2006 | WO2006010749A3 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | WO2005123721A3 Amorphous and polymorphic forms of candesartan cilexetil |
| 06/08/2006 | US20060122396 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents |
| 06/08/2006 | US20060122394 Substituted biaryl piperazinyl-pyridine analogues |
| 06/08/2006 | US20060122388 Thiocarbamate inhibitors of alpha-4 integrins |
| 06/08/2006 | US20060122289 Polymers |
| 06/08/2006 | US20060122254 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor (PAI-1) |
| 06/08/2006 | US20060122248 Methods of making 6-[(4,5-dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form |
| 06/08/2006 | US20060122235 Amine oxidase inhibitor; use in treating Alzheimer's disease; for example, (RS)-1-[6-(4-fluoro-benzyloxy)-pyridin-3-yl]-5-oxo-pyrrolidine-3-carboxylic acid methylamide |
| 06/08/2006 | US20060122233 Rabeprazole calcium |
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122222 Heterocycle substituted carboxylic acids |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122209 Process for preparing trisubstituted pyrimidine compounds |
| 06/08/2006 | US20060122206 3-[2-[4-(5-fluoro-1H-indol-3-yl)-1,2,3,6-tetrahydro-pyridin-1-yl]ethyl]-2,9-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one; antidepressant, neuroleptic, anxiolytic agent; nervous system disorders, Parkinson's disease, schizophrenia, autism, cognition activator |
| 06/08/2006 | US20060122204 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/08/2006 | US20060122202 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122197 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 06/08/2006 | US20060122196 Gyrase inhibitors and uses thereof |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/08/2006 | US20060122187 Pyridine derivatives as H3 antagonists |
| 06/08/2006 | US20060122182 Bioassay of testing the compound on the biological system or sample; antihistamines; bronchodilator agents, anticholinergic agents; respiratory system disorders; 2-{(S)-1-[5-(2-methylamino)acetylamino)pentyl]pyrrolidin-3-yl}-2,2-diphenylacetamide |
| 06/08/2006 | US20060122177 Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122175 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 06/08/2006 | US20060122170 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 06/08/2006 | US20060122123 Hepatitis C; 1-benzyloxycarbonylamino-2-vinyl-cyclopropyl)-phenyl-phosphinic acid ethyl ester |
| 06/08/2006 | US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 06/08/2006 | US20060120956 Imaging agents comprising barbituric acid derivatives |
| 06/08/2006 | CA2738383A1 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | CA2588949A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 06/08/2006 | CA2588947A1 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/08/2006 | CA2588457A1 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
| 06/07/2006 | EP1666458A1 Optically active 3,3 -dithiobis(2-amino-2-methylpropioni c acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methyl-propionic acid derivative |
| 06/07/2006 | EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664035A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 06/07/2006 | EP1664032A1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1664030A1 Quinazoline derivatives |
| 06/07/2006 | EP1664029A1 Quinazoline derivatives as antitumor agents |
| 06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
| 06/07/2006 | EP1663992A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663972A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders |
| 06/07/2006 | EP1663970A1 Matrix metalloproteinase inhibitors |
| 06/07/2006 | EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/07/2006 | EP1663959A1 Novel amidine compounds for treating microbial infections |
| 06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
| 06/07/2006 | EP1663235A1 Capped pyrazinoylguanidine sodium channel blockers |
| 06/07/2006 | EP1663211A1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 06/07/2006 | EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 06/07/2006 | EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis |
| 06/07/2006 | EP1599878B1 Optical recording materials having high storage density |
| 06/07/2006 | EP1599469B1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
| 06/07/2006 | EP1292593B1 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds |
| 06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |